Evidence map›Paper›PMID 41026980›Full record

SynthesisJournal of medical Internet research2025

Large Language Models in Lung Cancer: Systematic Review.

Ruikang Zhong, Siyi Chen, Zexing Li, Tangke Gao, Yisha Su, Wenzheng Zhang, Dianna Liu, Lei Gao, Kaiwen Hu

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruikang ZhongGraduate School, Beijing University of Chinese Medicine, Beijing, China.ORCID http://orcid.org/0000-0003-2086-2516
Siyi ChenGraduate School, Beijing University of Chinese Medicine, Beijing, China.ORCID http://orcid.org/0009-0009-7028-5244
Zexing LiGraduate School, Beijing University of Chinese Medicine, Beijing, China.ORCID http://orcid.org/0009-0009-8519-3190
Tangke GaoGraduate School, Beijing University of Chinese Medicine, Beijing, China.ORCID http://orcid.org/0009-0000-0915-4127
Yisha SuGraduate School, Beijing University of Chinese Medicine, Beijing, China.ORCID http://orcid.org/0009-0007-6680-2179
Wenzheng ZhangGraduate School, Beijing University of Chinese Medicine, Beijing, China.ORCID http://orcid.org/0009-0006-8425-8317
Dianna LiuOncology Department, Dongfang Hospital, Beijing University of Chinese Medicine, No. 6, Fangxingyuan 1st District, Fengtai District, Beijing, China, 86 13911650713.ORCID http://orcid.org/0000-0002-0085-8854
Lei Gao *Oncology Department, Dongfang Hospital, Beijing University of Chinese Medicine, No. 6, Fangxingyuan 1st District, Fengtai District, Beijing, China, 86 13911650713.ORCID http://orcid.org/0000-0002-1844-1491
Kaiwen Hu *Oncology Department, Dongfang Hospital, Beijing University of Chinese Medicine, No. 6, Fangxingyuan 1st District, Fengtai District, Beijing, China, 86 13911650713.ORCID http://orcid.org/0000-0002-1258-9647

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In the era of data and intelligence, artificial intelligence has been widely applied in the medical field. As the most cutting-edge technology, the large language model (LLM) has gained popularity due to its extraordinary ability to handle complex tasks and interactive features. Objective: This study aimed to systematically review current applications of LLMs in lung cancer (LC) care and evaluate their potential across the full-cycle management spectrum. Methods: Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we conducted a comprehensive literature search across 6 databases up to January 1, 2025. Studies were included if they satisfied the following criteria: (1) journal articles, conference papers, and preprints; (2) studies that reported the content of LLMs in LC; (3) including original data and LC-related data presented separately; and (4) studies published in English. The exclusion criteria were as follows: (1) books and book chapters, letters, reviews, conference proceedings; (2) studies that did not report the content of LLMs in LC; and (3) no original data, and LC-related data that are not presented separately. Studies were screened independently by 2 authors (SC and ZL) and assessed for quality using Quality Assessment of Diagnostic Accuracy Studies-2, Prediction Model Risk of Bias Assessment Tool, and Risk Of Bias in Non-randomized Studies - of Interventions tools, selected based on study type. Key data items extracted included model type, application scenario, prompt method, input and output format, outcome measures, and safety considerations. Data analysis was conducted using descriptive statistics. Results: Out of 706 studies screened, 28 were included (published between 2023 and 2024). The ability of LLMs to automatically extract medical records, popularize general knowledge about LC, and assist clinical diagnosis and treatment has been demonstrated through the systematic review, emerging visual ability, and multimodal potential. Prompt engineering was a critical component, with varying degrees of sophistication from zero-shot to fine-tuned approaches. Quality assessments revealed overall acceptable methodological rigor but noted limitations in bias control and data security reporting. Conclusions: LLMs show considerable potential in improving LC diagnosis, communication, and decision-making. However, their responsible use requires attention to privacy, interpretability, and human oversight.

Indexed as

Artificial IntelligenceLanguageLung NeoplasmsHumansLarge Language Modelsartificial intelligenceclinical practicediagnosisfull-cycle managementlarge language modelingLCLLMlung cancersystematic reviewtreatment

Identifiers

PMID41026980
PMCPMC12483341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.